Results 11 to 20 of about 73,106 (164)

Application of Immunohistochemistry in Papillary Thyroid Carcinoma

open access: yes, 2022
Immunohistochemistry (IHC) is an economic and precise method to localize the presence of specific protein at cellular level in tissue. Although many papillary thyroid carcinomas do not require IHC to render a diagnosis, there are certain scenarios in which IHC are important.
Lam, AK, Lee, KTW
openaire   +5 more sources

Histopathological Assessment for Papillary Thyroid Carcinoma

open access: yes, 2022
Histologic assessments of papillary thyroid carcinoma are crucial for management of patients with the cancer as well as research on the cancer as papillary thyroid carcinoma has different histologic subtypes and many parameters which are essential in predicting the biological aggressiveness of the cancer.
Lam, AK
openaire   +5 more sources

Papillary Thyroid Carcinoma: Current Position in Epidemiology, Genomics, and Classification

open access: yes, 2022
Papillary thyroid carcinoma is the most common type of thyroid malignancy both in adults and pediatric population. Since the 1980s, there are changes in criteria in labelling thyroid lesions as “papillary thyroid carcinomas.” Radiation exposure is a well-
Lam, AK
core   +1 more source

Assessment of Papillary Thyroid Carcinoma with Ultrasound Examination

open access: yes, 2022
Ultrasound examination of the thyroid is useful for preoperative assessment of thyroid nodules including papillary thyroid carcinoma. The examination mainly is to determine the malignant potential of thyroid nodule(s).
Lam, AK, Abe, I
core   +1 more source

Concepts of Pathological Staging and Prognosis in Papillary Thyroid Carcinoma

open access: yes, 2022
American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (AJCC/UICC) staging and American Thyroid Association (ATA) risk predication system are the best predicators of mortality and cancer recurrence, respectively, in patients ...
Lam, AK
core   +1 more source

Papillary Thyroid Carcinoma: Methods and Protocols

open access: yes, 2022
This detailed volume presents status and management protocols with the objective of identifying proper guidelines and materials for research related to the most common malignant neoplasm in the thyroid gland, papillary thyroid carcinoma.
Lam, Alfred K
core   +1 more source

Proteomic and Postproteomic Characterization of Keratan Sulfate-Glycanated Isoforms of Thyroglobulin and Transferrin Uniquely Elaborated by Papillary Thyroid Carcinomas. [PDF]

open access: yes, 2003
Previous studies have suggested that surface components of papillary thyroid carcinoma (PTC) cells may be aberrantly glycanated, but the precise nature of these molecules has not been unveiled nor documented to be of clinical relevance.
Colombatti, Alfonso   +39 more
core   +1 more source

External radiotherapy of thyroid cancer [PDF]

open access: yes, 2001
Differentiated thyroid cancer comprises papillary, mixed papillary-follicular and follicular adenocarcinomas. They are mostly hormone-sensitive and respond to thyroid-stimulating hormone (TSH) suppression. The standard treatment is total thyroidectomy. I-
Pollinger, B., Dühmke, Eckhart
core   +1 more source

Macroscopic Examination of Surgical Specimen of Papillary Thyroid Carcinoma

open access: yes, 2022
Standardized pathology reporting of thyroid cancer is important for quality clinical management, research as well as education purposes. International Collaboration on Cancer Reporting (ICCR) has produced a Dataset for reporting carcinoma of thyroid.
Lam, AK
core   +1 more source

Liposomal siRNA Delivery in Papillary Thyroid Carcinoma Cells

open access: yes, 2022
The discovery of RNA interference (RNAi) has opened a new strategy in cancer therapy, especially by silencing target genes. Pharmacologically it can be achieved by introducing of small (19–21 base pairs) dsRNA molecules known as small interfering RNA ...
Islam, F, Lam, AK, Zhou, Y
core   +1 more source

Home - About - Disclaimer - Privacy